John E. Davis - 02 Mar 2026 Form 4 Insider Report for ARTIVION, INC. (AORT)

Reporting relationship: Chief Commercial Officer
Issuer ticker: AORT
Reported as of: 02 Mar 2026
Net transaction value: -$172,748
SEC form: 4
Accepted by SEC: 04 Mar 2026, 18:49:24 UTC
Prior SEC filing: 25 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ John E. Davis

Key filing fact

John E. Davis filed Form 4 for ARTIVION, INC. (AORT) on 04 Mar 2026.

Key facts

This page summarizes John E. Davis's Form 4 filing for ARTIVION, INC. (AORT).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 04 Mar 2026, 18:49.

Change

Previous filing in this sequence was filed on 25 Feb 2026.
Current net transaction value: -$172,748.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001653206 Primary reporting owner

Davis John E

Relationship: Chief Commercial Officer
Address: 1655 ROBERTS BLVD., NW, KENNESAW
Signature: /s/ John E. Davis
Signature date: 04 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AORT transaction

Common Stock

Award

Transaction value
Shares: +28,845
Change %: +14%
Price: $0.000000^*
Shares after: 235,367
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F1

AORT transaction

Common Stock

Sale

Transaction value: $172,748
Shares: -4,573
Change %: -1.9%
Price: $37.78
Shares after: 230,794
Date: 03 Mar 2026
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents performance stock units granted on February 28, 2025. One third (1/3) were issued on March 2, 2026. The remaining shares earned in connection with the February 2025 grant will be eligible to vest and be issued as follows: one third (1/3) on February 28, 2027; and one third (1/3) on February 28, 2028, assuming employment on the relevant vesting date.

Footnote F2

These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction.